Skip to main content

Lipid-enriched and protein-enriched enteral nutrition limits inflammation in a human endotoxemia model

Introduction

Enteral administration of lipid-enriched nutrition was previously shown to attenuate inflammation and organ damage via a cholecystokinin-mediated vagovagal reflex in animal studies. The current proof-of-principle study investigates the immunomodulatory potential of enteral lipid-enriched and protein-enriched nutrition during experimental human endotoxemia.

Methods

After an overnight fast, 18 healthy male subjects received an intravenous bolus of Escherichia coli lipopolysaccharide (LPS; 2 ng/kg). Subjects in the fasted group (n = 6) were deprived of food throughout the study, while subjects in the intervention groups were fed either enriched (n = 6) or isocaloric control nutrition (n = 6) via a nasojejunal tube, starting 1 hour prior to LPS administration until 6 hours afterwards.

Results

LPS administration resulted in a marked inflammatory response. Continuous postpyloric administration of nutrition increased plasma cholecystokinin levels. Enriched nutrition attenuated circulating levels of the proinflammatory cytokines TNFα and IL-6 and the IL-1 receptor antagonist compared with control nutrition (all: P < 0.01) and fasted subjects (all: P < 0.05). Additionally, enriched nutrition augmented the anti-inflammatory response, reflected by increased IL-10 release compared with fasted subjects (P < 0.0001). See Figure 1.

Figure 1
figure1

Plasma cytokine levels in the three experimental groups.

Conclusions

The current study establishes the anti-inflammatory potential of enriched nutrition in humans. The immediate anti-inflammatory effect of enriched nutrition suggests that the beneficial effects are mediated via a cholecystokinin-dependent vagovagal reflex. Enteral administration of enriched nutrition is a promising intervention to modulate the immune response in the early course of systemic inflammation.

Author information

Affiliations

Authors

Corresponding author

Correspondence to M Kox.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Cite this article

Kox, M., Lubbers, T., De Haan, J. et al. Lipid-enriched and protein-enriched enteral nutrition limits inflammation in a human endotoxemia model. Crit Care 15, P383 (2011). https://doi.org/10.1186/cc9803

Download citation

Keywords

  • Cholecystokinin
  • Fast Subject
  • Fast Group
  • Immunomodulatory Potential
  • Enteral Administration